Cycling through all six. Tap any point to stop.

Measured on six things

Ellie helps you hold your weight after a GLP-1, whether you stay on, drop to a lower dose, or stop entirely.

Security

HTTPS and HSTS are solid, but missing CSP, frame protection, and DMARC leaves gaps. No security page, privacy policy, or compliance certifications found — typical for a new app but worth watching.

Screenshots

1 / 1

Ellie

About this app

Ellie is a companion app for the hardest part of a GLP-1 journey: keeping the weight off once the medication stops doing the holding. Most GLP-1 apps are shot trackers. They log an injection and draw a weight line. Ellie is built for the moment after that, when insurance denies the refill, a prescriber agrees to try a lower dose, side effects win, or the last pen was months ago. On average, people regain about two thirds of the weight within a year of stopping. That average describes people with no plan.

Key features

1Week-by-week After Plan tailored to your taper or discontinuation timeline, with phase-specific guidance.
2Food Noise SOS: a 10-minute protocol with a trend chart showing noise fading over weeks.
3Trend-line drift detection that catches weight gain at 4 lbs, not 20, with a 'Holding' status badge.

Target customer profile

Drawn from the product itself, not from a survey.

Scout Review

Written by AI from measured evidence, scored out of 100.

Ellie is a thoughtfully designed companion app for the GLP-1 after-life — a niche that's real, underserved, and growing. The design is calm and polished, the core features (After Plan, SOS, trend-line drift detection) are genuinely differentiated, and the messaging is backed by cited research. Usability is solid but lacks a help center and multi-language support. Speed is excellent on desktop but lags on mobile. Security is the weakest link — no CSP, no privacy policy, no compliance certifications — which is concerning for a health app. Accessibility is strong but has minor contrast and heading issues. Growth potential is high given the category's headroom, but the wedge is copyable and early traction is minimal. Overall, a promising product with a clear vision, but it needs to shore up security and support infrastructure to match its design ambition.

Measure by measure

Usability

Clear onboarding via prominent App Store CTA, intuitive status indicators, and SOS button. However, no help center or docs beyond one guide, and single-language support limits reach.

Design

Polished, calm aesthetic with consistent mauve palette, serif headlines, and realistic mockups. App UI is clean with clear data viz, though light tab bar and uneven stat cards are minor flaws.

Speed

Desktop is flawless (100/100), but mobile LCP of 5.4s is a real drag — likely the hero image and mockups. CLS of 0 is excellent; TBT is acceptable.

Security

HTTPS and HSTS are solid, but missing CSP, frame protection, and DMARC leaves gaps. No security page, privacy policy, or compliance certifications found — typical for a new app but worth watching.

Accessibility

Lighthouse 94/100 is strong, but contrast and heading order failures are real. No WCAG statement or multi-language support, though the site is responsive and keyboard-navigable in practice.

Growth

Targets a real, underserved gap — GLP-1 discontinuation — with a differentiated After Plan and SOS tool. Early traction is minimal but the wedge is clear and the category has headroom.

Improvement areas

Security: add CSP, DMARC, and a clear privacy policy; consider SOC 2 certification for health data trust.
Mobile performance: optimize LCP (currently 5.4s) by lazy-loading images and reducing font overhead.
Support: expand beyond one guide with a full help center and multi-language localization.

Design & Usability

Ellie's design is a breath of fresh air in the clinical GLP-1 space — soft mauve tones, a serif headline, and a hummingbird mascot that somehow feels earned, not gimmicky. The app UI mirrors the site's calm aesthetic, with clean data viz (weight trend, protein ring) and clear status badges like 'Holding' and 'past your floor.' Usability is solid: the App Store CTA is prominent, the SOS button is a smart touch for the core use case, and the bottom nav is intuitive. However, the light tab bar blends into the background, and the lack of a help center or docs beyond one guide is a gap — users navigating a complex health journey need more than a FAQ. The single-language support also limits accessibility for non-English speakers. Overall, a well-crafted product that's easy to pick up, but the support infrastructure needs to catch up with the design polish.

Speed & Security

Speed is a mixed bag: desktop performance is flawless at 100/100, but mobile LCP of 5.4s is a significant bottleneck — likely the hero mockups and serif font rendering. CLS of 0 is excellent, and TBT is acceptable, so the site feels snappy once loaded. Security is a concern for a health app: HTTPS and HSTS are in place, but the absence of CSP, frame protection, and DMARC leaves it vulnerable to common attacks. No security page, privacy policy, or compliance certifications (SOC 2, ISO) were found — for an app handling sensitive health data, this is a red flag that needs addressing. The app is free with a subscription, but users should know how their data is handled. The measured checklist score of 5/12 reflects these gaps. While the product is new, security should be a priority from day one, not an afterthought.

Accessibility & Growth

Accessibility is a strength with a few caveats: the Lighthouse score of 94/100 is impressive, but the failing audits — insufficient color contrast and non-sequential heading order — are fixable and should be addressed. No WCAG statement or multi-language support was found, which limits the app's reach. Growth potential is the most compelling part of Ellie's story. It targets a real, underserved problem: the lack of protocols for GLP-1 discontinuation, backed by cited data (STEP-1, SURMOUNT-4, Cleveland Clinic). The differentiators — the After Plan, Food Noise SOS, drift detection at 4 lbs, and bring-to-prescriber export — are concrete and not offered by shot-tracker competitors. The category has headroom as GLP-1 usage grows, but the wedge is narrow and copyable. Early traction is minimal (1 rating, 0.1-year-old domain), but the idea is strong enough to build on.

Conclusion

Ellie has found a genuine gap in the GLP-1 market and filled it with a well-designed, empathetic product. The After Plan and SOS tools are smart, the data viz is clean, and the messaging avoids the clinical coldness of competitors. But the app is early — one rating, one language, one guide — and the security posture needs work before it can be trusted with sensitive health data. If the team can address the mobile speed, add a proper help center, and publish a clear privacy policy, Ellie could become the go-to companion for the millions navigating life after GLP-1s. For now, it's a promising start with a clear path forward. Download it, log your first morning, and let the trend line start working — but keep an eye on the security page (when it exists).

Suggestions for improvement

Add a comprehensive help center with guides, FAQs, and video tutorials to support users through the After Plan.
Publish a clear privacy policy and security page, and consider pursuing SOC 2 or similar certification to build trust.
Optimize mobile performance by lazy-loading hero images and reducing font rendering overhead to improve LCP.
Expand language support and add a WCAG accessibility statement to reach a broader, more inclusive audience.

How we score

Alternatives comparison

Named competitors, point by point. Nobody paid to appear here or to be left out.

	Ellie
GLP-1 discontinuation support	Dedicated After Plan with week-by-week timeline, SOS tool, and drift detection	No specific discontinuation protocol found
Shot tracking	Records regimen but never suggests doses; focuses on maintenance	Likely standard injection logging and weight tracking
Data-driven insights	Trend-line drift detection, protein/strength floor, noise trend chart	Basic weight and dose logging; no predictive or drift analysis
Prescriber collaboration	One-page export with regimen, trend, and plan for doctor visits	No export or prescriber-facing feature mentioned
Community support	Community tab in bottom nav; SOS button for immediate help	No community or SOS features indicated